VEGF Receptor 2 Recombinant Rabbit Monoclonal Antibody [SU03-42]
Catalog# ET1608-33
VEGF Receptor 2 Recombinant Rabbit Monoclonal Antibody [SU03-42]
-
WB
-
IF-Cell
-
IHC-P
-
IP
-
Human
-
Rat
-
unconjugated
Safety datasheet
Select your chosen country/region
- MSDS_HUABIO.pdf
- MSDS_HUABIO.pdf
- MSDS_ET1608-33_Europe.pdf
- No MSDS Found
製品概要
製品名
VEGF Receptor 2 Recombinant Rabbit Monoclonal Antibody [SU03-42]
抗体のタイプ
Recombinant Rabbit monoclonal Antibody
免疫原
Recombinant protein within Human VEGF Receptor 2 aa 30-630 / 1,356.
交差反応性(対応種属)
Human, Rat
検証済みアプリケーション
WB, IF-Cell, IHC-P, IP
標的分子量
Predicted band size: 152 kDa
ポジティブコントロール
Human lung tissue lysate, human placenta tissue, human kidney tissue, A431, HUVEC, PMVEC.
コンジュゲーション
unconjugated
クローン番号
SU03-42
RRID
製品の特徴
形態
Liquid
濃度
保存方法
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
保存バッファー
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
アイソタイプ
IgG
精製方法
Protein A affinity purified.
推奨希釈倍率
-
WB
-
1:500-1:1,000
-
IF-Cell
-
1:50-1:200
-
IHC-P
-
1:200
-
IP
-
Use at an assay dependent concentration.
ターゲット
機能
Kinase insert domain receptor (KDR, a type IV receptor tyrosine kinase) also known as vascular endothelial growth factor receptor 2 (VEGFR-2) is a VEGF receptor. KDR is the human gene encoding it. KDR has also been designated as CD309 (cluster of differentiation 309). KDR is also known as Flk1 (Fetal Liver Kinase 1). The Q472H germline KDR genetic variant affects VEGFR-2 phosphorylation and has been found to associate with microvessel density in NSCLC.
背景・参考文献
1. Li W et al. Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration. Drug Des Devel Ther 10:3415-3423 (2016).
2. Wang TC et al. Characterization of highly proliferative secondary tumor clusters along host blood vessels in malignant glioma. Mol Med Rep 12:6435-44 (2015).
配列相同性
Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.
組織特異性
Detected in cornea (at protein level). Widely expressed.
翻訳後修飾(PTM)
N-glycosylated.; Ubiquitinated. Tyrosine phosphorylation of the receptor promotes its poly-ubiquitination, leading to its degradation via the proteasome or lysosomal proteases.; Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-951 is important for interaction with SH2D2A/TSAD and VEGFA-mediated reorganization of the actin cytoskeleton. Phosphorylation at Tyr-1175 is important for interaction with PLCG1 and SHB. Phosphorylation at Tyr-1214 is important for interaction with NCK1 and FYN. Dephosphorylated by PTPRB. Dephosphorylated by PTPRJ at Tyr-951, Tyr-996, Tyr-1054, Tyr-1059, Tyr-1175 and Tyr-1214.; The inhibitory disulfide bond between Cys-1024 and Cys-1045 may serve as a specific molecular switch for H(2)S-induced modification that regulates KDR/VEGFR2 function.
サブセルラー局在
Cytoplasm, Nucleus, Cell junction, Endoplasmic reticulum, Cell membrane, Early endosome, Secreted.
UNIPROT #
別名
CD309 antibody
CD309 antigen antibody
EC 2.7.10.1 antibody
Fetal liver kinase 1 antibody
FLK-1 antibody
FLK1 antibody
FLK1, mouse, homolog of antibody
Kdr antibody
Kinase insert domain receptor (a type III receptor tyrosine kinase) antibody
Kinase insert domain receptor antibody
詳細を見るCD309 antibody
CD309 antigen antibody
EC 2.7.10.1 antibody
Fetal liver kinase 1 antibody
FLK-1 antibody
FLK1 antibody
FLK1, mouse, homolog of antibody
Kdr antibody
Kinase insert domain receptor (a type III receptor tyrosine kinase) antibody
Kinase insert domain receptor antibody
KRD1 antibody
Ly73 antibody
Protein tyrosine kinase receptor FLK1 antibody
Protein-tyrosine kinase receptor flk-1 antibody
soluble VEGFR2 antibody
Tyrosine kinase growth factor receptor antibody
Vascular endothelial growth factor receptor 2 antibody
VEGFR 2 antibody
VEGFR antibody
VEGFR-2 antibody
VEGFR2 antibody
VGFR2_HUMAN antibody
閉じる画像
-
☑ Relative expression (RE)
Western blot analysis of VEGF Receptor 2 on different lysates with Rabbit anti-VEGF Receptor 2 antibody (ET1608-33) at 1/1,000 dilution.
Lane 1: Human lung tissue lysate
Lane 2: HeLa cell lysate (negative)
Lysates/proteins at 20 µg/Lane.
Predicted band size: 152 kDa
Observed band size: 152 kDa
Exposure time: 1 minute 18 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1608-33) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human placenta tissue with Rabbit anti-VEGF Receptor 2 antibody (ET1608-33) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-33) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human kidney tissue with Rabbit anti-VEGF Receptor 2 antibody (ET1608-33) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH 6.0) (high pressure) for 2 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-33) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
ICC staining VEGF Receptor 2 in A431 cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
-
ICC staining VEGF Receptor 2 in HUVEC cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
-
ICC staining VEGF Receptor 2 in PMVEC cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
ご注意: 本製品はすべて「研究用試薬」です。人や動物の診断・治療目的、または臨床診断には使用できません。(FOR RESEARCH USE ONLY)
文献・引用論文
-
Biomaterial-Based Lymphangiogenesis-Enhanced Therapeutic Strategy for Robustly-Integrated Medication-Related Osteonecrosis of Jaw Prevention
ジャーナル: ACS Applied Materials & Interfaces
DOI: 10.1021/acsami.5c02812
IF: 8.2
アプリケーション: IF-cell
交差反応性: Human
掲載日: 2025 Jun
-
HucMSCs can alleviate abnormal vasculogenesis induced by high glucose through the MAPK signaling pathway
ジャーナル: iScience
DOI:
IF: 4.6
アプリケーション: IF-cell
交差反応性: Human
掲載日: 2024 Nov
-
Intervention of exogenous VEGF protect brain microvascular endothelial cells from hypoxia-induced injury by regulating PLCγ/RAS/ERK and PI3K/AKT pathways
ジャーナル: Experimental Gerontology
DOI: 10.1016/j.exger.2024.112452
IF: 3.3
アプリケーション: WB
交差反応性: Mouse
掲載日: 2024 May
-
Allicin in pregnancy diets modulates steroid metabolism in pregnant sows and placental sulfate metabolism promoting placental angiogenesis and fetal development
ジャーナル: Animals
DOI:
IF: 3.7
アプリケーション: WB
交差反応性: Pig
掲載日: 2024 Jun
-
Efficacy and safety of apatinib combined with dose-dense paclitaxel and carboplatin in neoadjuvant therapy for locally advanced triple-negative breast cancer: A prospective cohort study with propensity-matched analysis
ジャーナル: International Journal Of Cancer
DOI: 10.1002/ijc.34717
IF: 6.4
アプリケーション: IHC-P
交差反応性: Human
掲載日: 2023 Sept
-
Antibacterial and Angiogenic (2A) Bio-Heterojunctions Facilitate Infectious Ischemic Wound Regeneration via an Endogenous-Exogenous Bistimulatory Strategy
ジャーナル: Advanced Materials
DOI:
IF: 29.4
アプリケーション: WB
交差反応性: Mouse
掲載日: 2023 Oct
-
Exploring the molecular mechanism of berberine for treating diabetic nephropathy based on network pharmacology
ジャーナル: International Immunopharmacology
DOI: 10.1016/j.intimp.2023.111237
IF: 5.6
アプリケーション: WB
交差反応性: Mouse
掲載日: 2023 Nov
-
URP20 improves corneal injury caused by alkali burns combined with pathogenic bacterial infection in rats
ジャーナル: Experimental Eye Research
DOI:
IF: 3.4
アプリケーション: WB
交差反応性: Rat
掲載日: 2023 Nov
-
Preparation of Ultra-Small Copper Nanoparticles-Loaded Self-Healing Hydrogels with Antibacterial, Inflammation-Suppressing and Angiogenesis-Enhancing Properties for Promoting Diabetic Wound Healing
ジャーナル: International Journal Of Nanomedicine
DOI:
IF: 8.0
アプリケーション: WB
交差反応性: Human,Mouse
掲載日: 2023 Jun
-
N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma
ジャーナル: Molecular Cancer
DOI:
IF: 41.444
アプリケーション: WB
交差反応性: Human
掲載日: 2022 May
Alternative Products
VEGF Receptor 2 Recombinant Rabbit Monoclonal Antibody [SU03-42]
Application: WB,IF-Cell,IHC-P,IP
Reactivity: Human,Rat
Conjugate: unconjugated
同一ターゲット&同一シグナル伝達経路の関連製品
Biotin Conjugated Human VEGF Receptor 2 Recombinant Rabbit Monoclonal Antibody [PSH12-84] - Detector
Application: ELISA(Det),ELISA
Reactivity: Human
Conjugate: Biotin
Human VEGF Receptor 2 Recombinant Rabbit Monoclonal Antibody [PSH12-83] - BSA and Azide free (Capture)
Application: ELISA(Cap)
Reactivity: Human
Conjugate: unconjugated
VEGF Receptor 2 Mouse Monoclonal Antibody [1G1]
Application: WB,IP,IF,IHC-P
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Human VEGF Receptor 2 Recombinant Rabbit Monoclonal Antibody [PSH12-84] - BSA and Azide free (Detector)
Application: ELISA(Det)
Reactivity: Human
Conjugate: unconjugated